Literature DB >> 25876531

More art than science: impedance analysis prone to interpretation error.

Thomas Ciecierega1, Benjamin L Gordon, Anna Aronova, Carl V Crawford, Rasa Zarnegar.   

Abstract

BACKGROUND: Impedance monitoring for reflux evaluation does not have standardized scoring, which can confound interpretation between observers. We investigated the variability of impedance testing interpretation between physicians and computer software.
METHODS: Raw impedance data from 38 patients that underwent impedance monitoring at a tertiary referral center between 2008 and 2013 were collected. Two physicians and computer software each analyzed the same impedance dataset for reflux activity and symptom-reflux correlation.
RESULTS: Normalized reflux activity interpretations did not differ between physicians and the computer for acid or non-acid reflux. However, for weakly acidic reflux, there was significant difference between physicians (p < 0.01) and between physician and computer (p < 0.01). In analyzing all reflux, significant variability existed between physicians (p < 0.01) but not between physician and computer. Variability in interpretation altered diagnosis in 24 % of patients when comparing between physicians, 18 % of patients when comparing both physicians to the computer, and an additional 24 % of cases when comparing a single physician to the computer. Symptom-reflux correlation differed in 7 % of physician-physician comparisons versus 8 % of computer-physician comparisons.
CONCLUSION: Impedance testing analysis is subject to marked variability between physicians and computer software, making impedance prone to interpretation error that can lead to differences in diagnosis and management.

Entities:  

Mesh:

Year:  2015        PMID: 25876531     DOI: 10.1007/s11605-015-2809-0

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  30 in total

1.  Esophageal impedance monitoring: the ups and downs of a new test.

Authors:  Steven Shay
Journal:  Am J Gastroenterol       Date:  2004-06       Impact factor: 10.864

2.  Inter-observer agreement for multichannel intraluminal impedance-pH testing.

Authors:  K Ravi; K R DeVault; J A Murray; E P Bouras; D L Francis
Journal:  Dis Esophagus       Date:  2010-04-29       Impact factor: 3.429

Review 3.  Epidemiology of gastro-oesophageal reflux disease: a systematic review.

Authors:  J Dent; H B El-Serag; M-A Wallander; S Johansson
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

Review 4.  Time trends of gastroesophageal reflux disease: a systematic review.

Authors:  Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2006-12-04       Impact factor: 11.382

5.  Meta-analysis: the effects of placebo treatment on gastro-oesophageal reflux disease.

Authors:  F Cremonini; D C Ziogas; H Y Chang; E Kokkotou; J M Kelley; L Conboy; T J Kaptchuk; A J Lembo
Journal:  Aliment Pharmacol Ther       Date:  2010-03-26       Impact factor: 8.171

6.  Interobserver and intraobserver variability in pH-impedance analysis between 10 experts and automated analysis.

Authors:  Clara M Loots; Michiel P van Wijk; Kathleen Blondeau; Kasper Dalby; Laura Peeters; Rachel Rosen; Silvia Salvatore; Tobias G Wenzl; Yvan Vandenplas; Marc A Benninga; Taher I Omari
Journal:  J Pediatr       Date:  2011-09-15       Impact factor: 4.406

7.  ACG practice guidelines: esophageal reflux testing.

Authors:  Ikuo Hirano; Joel E Richter
Journal:  Am J Gastroenterol       Date:  2007-03       Impact factor: 10.864

8.  Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice.

Authors:  T L Venables; R D Newland; A C Patel; J Hole; C Wilcock; M L Turbitt
Journal:  Scand J Gastroenterol       Date:  1997-10       Impact factor: 2.423

9.  Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility.

Authors:  J R Jamieson; H J Stein; T R DeMeester; L Bonavina; W Schwizer; R A Hinder; M Albertucci
Journal:  Am J Gastroenterol       Date:  1992-09       Impact factor: 10.864

10.  Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics.

Authors:  Mattijs E Numans; Joseph Lau; Niek J de Wit; Peter A Bonis
Journal:  Ann Intern Med       Date:  2004-04-06       Impact factor: 25.391

View more
  3 in total

Review 1.  Gastroesophageal reflux disease: A review of surgical decision making.

Authors:  Maureen Moore; Cheguevara Afaneh; Daniel Benhuri; Caroline Antonacci; Jonathan Abelson; Rasa Zarnegar
Journal:  World J Gastrointest Surg       Date:  2016-01-27

2.  Comparison of multichannel intraluminal impedance-pH monitoring and reflux scintigraphy in pediatric patients with suspected gastroesophageal reflux.

Authors:  Nuray Uslu Kızılkan; Murat Fani Bozkurt; Inci Nur Saltık Temizel; Hülya Demir; Aysel Yüce; Biray Caner; Hasan Özen
Journal:  World J Gastroenterol       Date:  2016-11-21       Impact factor: 5.742

3.  Role of the Mean Nocturnal Baseline Impedance in Identifying Evidence Against Pathologic Reflux in Patients With Refractory Gastroesophageal Reflux Disease Symptoms as Classified by the Lyon Consensus.

Authors:  Yanhong Wu; Zihao Guo; Chuan Zhang; Yutao Zhan
Journal:  J Neurogastroenterol Motil       Date:  2022-01-30       Impact factor: 4.924

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.